TNFRSF10B and head and neck squamous cell carcinoma: These HPV(+) HNSCC lines displayed resistance to birinapant treatment as a single agent in vitro, while exhibited sensitivity to the treatment of combined birinapant, TRAIL and TRAILR2 agonist antibody, which mediated death signaling through apoptosis.